We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $490M
1-Year Est. Return 35.11%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
+35.11%
3 Year Est. Return
+110.51%
5 Year Est. Return
+106.45%
10 Year Est. Return
AUM
$405M
AUM Growth
-$46.4M
Cap. Flow
-$17.1M
Cap. Flow %
-4.21%
Top 10 Hldgs %
24.86%
Holding
295
New
19
Increased
115
Reduced
99
Closed
22

Sector Composition

1 Technology 20.16%
2 Consumer Discretionary 14.26%
3 Financials 10.8%
4 Communication Services 8.84%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
251
Relay Therapeutics
RLAY
$4.34B
$161K 0.04%
61,425
NAC icon
252
Nuveen California Quality Municipal Income Fund
NAC
$1.87B
$153K 0.04%
13,500
WULF icon
253
TeraWulf
WULF
$9B
$104K 0.03%
38,000
+11,500
+43% +$51.2K
SNAP icon
254
Snap
SNAP
$7.62B
$103K 0.03%
+11,880
New +$124K
AFMD
255
DELISTED
Affimed
AFMD
$91.4K 0.02%
126,414
PL icon
256
Planet Labs
PL
$8.01B
$91.3K 0.02%
27,000
-14,000
-34% -$65.6K
QNCX icon
257
Quince Therapeutics
QNCX
$18.5M
$70.9K 0.02%
+267
New +$81.5K
IMTX icon
258
Immatics
IMTX
$1.31B
$69.9K 0.02%
+15,500
New +$80.9K
CMPS
259
Compass Pathways
CMPS
$1.67B
$28.9K 0.01%
10,100
PLUG icon
260
Plug Power
PLUG
$3.03B
$16.7K ﹤0.01%
12,400
PRTS icon
261
CarParts.com
PRTS
$42.9M
$12.1K ﹤0.01%
1,205
-270
-18% -$2.96K
CBIO
262
Crescent Biopharma
CBIO
$407M
$9.65K ﹤0.01%
460
NKTR icon
263
Nektar Therapeutics
NKTR
$2.31B
$6.8K ﹤0.01%
667
TBLAW
264
DELISTED
Taboola.com Ltd Warrant
TBLAW
$6.24K ﹤0.01%
38,500
NUVB.WS
265
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$4.42K ﹤0.01%
22,396
MNTSW icon
266
Momentus Inc Warrant
MNTSW
$134
$790 ﹤0.01%
34,954
PXSAW
267
DELISTED
Pyxis Tankers Inc Warrant
PXSAW
$482 ﹤0.01%
24,000
AAON icon
268
Aaon
AAON
$9.13B
-1,883
Closed -$222K
BKSY.WS icon
269
BlackSky Technology Inc Warrants
BKSY.WS
$1.1M
$0 ﹤0.01%
+35,994
New +$7.86K
CL icon
270
Colgate-Palmolive
CL
$74.4B
-8,282
Closed -$753K
CRSP icon
271
CRISPR Therapeutics
CRSP
$4.71B
-7,131
Closed -$281K
CVS icon
272
CVS Health
CVS
$137B
-7,721
Closed -$347K
FTCS icon
273
First Trust Capital Strength ETF
FTCS
$7.88B
-3,100
Closed -$272K
GNTX icon
274
Gentex
GNTX
$5.19B
-8,464
Closed -$243K
GTLB icon
275
GitLab
GTLB
$5.53B
-3,550
Closed -$200K

Similar funds

Intellectus Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Intellectus Partners held 295 positions worth $405M, down 10% from $452M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Intellectus Partners withdrew a net $17.1M in Q1 2025, closing 22 positions and reducing 99 holdings. Its most notable exit was Vanguard Total Stock Market ETF, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Intellectus Partners opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $1.7M.

  • Intellectus Partners's largest Q1 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 18,531 shares worth $1.7M.
  • Intellectus Partners added most to Goldman Sachs Access Treasury 0-1 Year ETF in Q1 2025, an estimated $1.97M increase.
  • Intellectus Partners's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $16.8M.
  • Intellectus Partners fully exited Vanguard Total Stock Market ETF in Q1 2025, selling an estimated $2.12M.
  • Intellectus Partners's ten largest holdings make up 25% of its $405M portfolio in Q1 2025.
  • Intellectus Partners opened 19 new positions and closed 22 in Q1 2025.
  • Intellectus Partners's portfolio value fell 10% quarter-over-quarter to $405M.

Based on Intellectus Partners's 13F filing for Q1 2025, filed 11 Apr 2025.